Ominsky, Michael S <br/><br/>
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  May 2011 
 - 1012-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1002/jbmr.307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Animals<br/>Antibodies, Monoclonal--administration & dosage<br/>Biomechanical Phenomena--drug effects<br/>Bone Density--drug effects<br/>Diaphyses--drug effects<br/>Disease Models, Animal<br/>Femoral Fractures--physiopathology<br/>Femur--drug effects<br/>Fibula--drug effects<br/>Fracture Healing--drug effects<br/>Glycoproteins--antagonists & inhibitors<br/>Intercellular Signaling Peptides and Proteins<br/>Macaca fascicularis<br/>Male<br/>Organ Size--drug effects<br/>Osteogenesis--drug effects<br/>Osteotomy<br/>Rats<br/>Rats, Sprague-Dawley